Cowen Very Positive Comments on Results

Eric Schmidt, arguably the best and most influential wall street analyst at Cowen & Co, is quite positive on the abstracts and finds the stock significantly undervalued at these levels. He is the axe on the stock and is very measured and experienced in his analysis..

Yes---I have read his analysis of the abstracts and his resulting investment implication. I would agree that Institutions sitting on the sidelines will push this micro cap significantly higher. He notes that sucess in pancreatic cancer and sarcoma could drive sales to $ 1.5 billion+ in the US alone, with THLD likely to receive around 30 per cent of the economics. With a fully diluted enterprise value of around $450mm the stock will continue outperforming throughout the year. I think we can see a mid-teens on the stock this year.

Yahoo! Finance Worldwide

Quotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.